AptarGroup, Inc.

ATR Healthcare Medical Instruments & Supplies

AptarGroup, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.8 billion, up 5.42% from fiscal 2024. In the quarter to June 2026, revenue grew 6.26%, EPS fell 18.3%, free cash flow fell 23.1% and total debt rose 66.4%, each against the same quarter a year earlier. Dividend growth for ten consecutive years, revenue growth for ten.

124.51 0.25 +0.20%
Market cap
$7.9B
P/E
22.2×
Fwd P/E
21.0×
Dividend yield
1.54%
F-score
5/9
Altman Z
3.78
Beneish M
−2.48
Dividend safety
92/100
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
ROE
13.52% 14.87% 15.19% 15.70%

+8 more TTM periods

Piotroski F-Score
6 6 5 7
ROA
7.25% 8.03% 8.11% 8.62%
ROIC
7.82% 8.18% 8.33% 8.64%
Return on Tangible Assets
15.46% 16.34% 16.34% 21.80%
Average Days of Receivables
83.30 78.53 77.68 79.63
Free Cash Flow per Share
4.94 5.13 4.53 4.70
Free Cash Flow
314.58 328.66 298.11 308.70
Capital Expenditures
(268.89) (277.29) (271.89) (255.84)
Other line items
Cash ROIC
7.47% 7.75% 6.51% 7.26%
Accounts Receivable Turnover
4.63 4.91 5.17 4.89
Accounts Payable Turnover
2.95 3.06 3.06 2.80
Inventory Turnover
4.54 4.74 4.75 4.38
Average Days of Payables
128.80 125.14 126.60 136.01
Days of Inventory on Hand
84.21 82.08 82.75 88.13
Tax Rate
(0.20) (0.19) (0.20) (0.19)
Research and Development Expense of Revenue
0.00% 0.00% 0.00% 0.00%
Selling, General and Administrative Expense of Revenue
15.90% 15.98% 16.06% 16.21%
Share Based Compensation of Revenue
1.04% 1.07% 1.16% 1.27%
Interest Coverage
7.52 8.49 9.50 10.93
Operating CF/Net income
1.61 1.57 1.45 1.35
Depreciation/Fixed assets
0.19 0.18 0.17 0.17
Capex/Depreciation
(0.88) (0.93) (0.95) (0.92)
Revenue per Share
61.81 60.46 57.46 55.74
Operating CF per Share
9.17 9.46 8.67 8.59
Capex per Share
(4.23) (4.33) (4.14) (3.89)
Capex to Sales
0.07 0.07 0.07 0.07

Fold the line items

Columns are period end dates